Skip to main content
LobbyMap

Pacific Pharma Capital

Telecommunications · Lobbying Client

C
Influence Score
42/100
Moderate Influence
$721K
Total Lobby Spend
5
Policy Issues
1
Lobbyists
0
Revolving Door

Pacific Pharma Capital reported $721,000 in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 5 policy areas, with primary focus on Telecommunications, Communications/Broadcasting, Government Issues. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of State
Dept of Labor
Federal Trade Commission
Dept of Education
Dept of Transportation
Federal Energy Regulatory Commission

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarAkin Gump LLP
TECALCCOM+2
1$36K
2020 Apr-JunAkin Gump LLP
GOVCOM
1$27K
2020 Jul-SepBGR Group LLP
PHAGOV
1$33K
2020 Oct-DecCovington & Burling LLP
TECGOVPHA
1$30K
2021 Jan-MarHolland & Knight LLP
TECCOMPHA+2
1$53K
2021 Apr-JunBrownstein Hyatt LLP
GOVPHATEC
1$41K
2021 Jul-SepBrownstein Hyatt LLP
COMALCTEC
1$35K
2021 Oct-DecCassidy & Associates LLP
PHA
1$45K

Pacific Pharma Capital Lobbying FAQ

Pacific Pharma Capital has spent $721K on federal lobbying across 5 policy areas. This includes spending on registered lobbyists and direct government contacts.

Pacific Pharma Capital lobbies on 5 policy issues, including Telecommunications, Communications/Broadcasting, Government Issues, Pharmacy. These disclosures are filed quarterly with the Senate Office of Public Records.

Pacific Pharma Capital has an Influence Score of 42/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Pacific Pharma Capital employs 1 registered lobbyists, of whom 0 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Pacific Pharma Capital has contacted 6 government entities as part of their lobbying activities, including Dept of State, Dept of Labor, Federal Trade Commission.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.